Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Timeline

Pfizer

US pharmaceutical major; strategic investor in CellCentric's £170m Series D.

2 of 2 entries (2 events, 0 interactions)

Filters
#45 May

Participated as strategic co-investor in CellCentric $220m Series D

UK Startups and Innovation: CellCentric raises Europe's largest 2026 biotech round